Table II.
TCGA cohort | GEO cohort | |||||
---|---|---|---|---|---|---|
|
|
|||||
Characteristic | High risk | Low risk | P-value | High risk | Low risk | P-value |
Age, years | <0.01a | <0.01a | ||||
<60 | 29 | 57 | 12 | 30 | ||
≥60 | 171 | 143 | 70 | 53 | ||
Sex | 0.30a | 0.97a | ||||
Female | 56 | 47 | 15 | 15 | ||
Male | 144 | 153 | 67 | 68 | ||
Grade | <0.01b | <0.01a | ||||
High | 197 | 180 | 48 | 12 | ||
Low | 1 | 19 | 34 | 71 | ||
Unknown | 2 | 1 | ||||
TMN stage | <0.01b | - | ||||
I+II | 37 | 92 | - | - | ||
III+IV | 162 | 107 | - | - | ||
Unknown | 1 | 1 | - | - | ||
Muscle invasion | - | <0.01a | ||||
Yes | - | - | 47 | 15 | ||
No | - | - | 35 | 68 |
χ2 test;
Fisher's exact test. GEO, Gene Expression Omnibus; TCGA, The Cancer Genome Atlas.